PMS15 COST-EFFECTIVENESS OF THE TREATMENT FOR EARLY RHEUMATOID ARTHRITIS IN MEXICO- INFLIXIMAB VS. ADALIMUMAB
Abstract
Authors
E Mucino R Rivas L Zapata
E Mucino R Rivas L Zapata
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now